GH Guardant Health, Inc.

NEUTRAL Impact: 2/10 Insider Cluster (6 insiders)
Horizon days Filed May 26, 2026 Processed 11d 3h ago
Insider cluster: 6 insiders, $4.4M total

Price Chart

Loading chart...

Executive Summary

Six Guardant Health insiders sold a total of $4.36M in open-market sales over a 7-day window, led by the Chief Commercial Officer ($2.90M) and a Director ($735K). The cluster includes the Co-CEO ($20K), CLO ($593K), and two other directors. At $15.8B market cap, the total represents ~0.03% of market cap — a trivial proportion. The sales are likely liquidity-driven (option exercises and vesting) and carry no bearish signal per academic literature on cluster sells.

Key Financial Metrics

Direction
selling
Total Value
$4.4M
Insiders
6

Actionable Insight

This cluster is routine and non-informative. The sales are overwhelmingly tied to option exercises and tax planning, not a coordinated bearish view. Monitor the next earnings release for fundamental trends, but this insider activity alone does not warrant a trade.

Key Facts

  • 6 insiders sold shares totaling $4.36M in open-market transactions over 7 days
  • Chief Commercial Officer Freeman sold 24,406 shares at $118.67 for $2.90M — largest trade
  • Director Clark sold 6,876 shares at $106.90 for $735K
  • Chief Legal Officer Saia sold 5,632 shares at $105.34 for $593K
  • Co-CEO Talasaz sold only 200 shares at $100.95 for $20K — negligible
  • Total sales represent ~0.03% of $15.8B market cap — well below 0.1% materiality threshold
  • Multiple sales coincide with derivative exercises (Freeman exercised 24,406 options at $32.86; Hidalgo exercised 2,000 options at $32.55)
  • No open-market purchases were made by any insider in this cluster

Financial Impact

Total insider sales of $4.36M represent 0.03% of $15.8B market cap — immaterial

insider_salesdilution

Risk Factors

  • Insider selling could accelerate if stock continues to appreciate, but no evidence of informed selling here
  • Option exercises add ~50K shares to float, but dilution is negligible at 0.05% of shares outstanding

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
88% bullish (33 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GH-1779831510855
14 reports for GH
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+1▲ +4.43%May 27, 2026
Filters
Rows
Reports for GH — sortable, filterable
Type Now
Jun 5, 2026
1d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
Jun 4, 2026
2d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 29, 2026
8d ago
Insider Cluster
NEUTRAL ★ 2/10
$128.42 $130.17▲ +1.36%▲ +1.21%$125.61 (−2.19%)
May 29, 2026
8d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 28, 2026
9d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 27, 2026
11d ago
Court Ruling
BULLISH ★ 6/10
$127.45 $133.09▲ +4.43%▲ +3.87%$125.61 (−1.45%)
May 26, 2026
11d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
May 22, 2026
15d ago
144
BEARISH ★ 5/10
$119.29 $127.45▼ −6.84%▼ −6.83%$125.61 (−5.29%)
May 22, 2026
15d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
May 22, 2026
15d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (12h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access